ImmunoGen, Inc. · Waltham, MA United States (NASDAQ: IMGN)
| 830 Winter St. | Phone: 781-895-0600 |
| Waltham, MA | Fax: 781-895-0611 |
| 02451 | |
| United States | 
Map This Company |
ImmunoGen, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation Mfg, Cosmetics & Toiletries WholesalersCompany Description
ImmunoGen is TAP, TAP, TAPping its way toward a cure for cancer. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs with monoclonal antibodies (single-source proteins) and attach only to tumor cells. Its lead compounds are trastuzumab emtansine, which is being developed with
ImmunoGen, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: IMGN Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Employees | 248 |
Executives
24 executives listed for ImmunoGen, Inc.'s Waltham, MA location.
| Chairman | Stephen McCluski | |
|---|---|---|
| President, CEO, and Director | Daniel Junius | |
| SVP and CFO | Gregory Perry |